how were glp 1 agonists discovered GLP-1R for Weight Loss Machine-Learning-Guided Peptide Drug Discovery: Development
Description
Frequently Asked Questions What is the difference between GLP-1 and GIP
Zhang T, Cheng JK, Hu YM
Chang MG, Bittner EA
announced the decision to discontinue the development of danuglipron (PF-06882961), an oral glucagon-like peptide-1 (GLP-1) receptor agonist, which was being investigated for chronic weight management
Glucagonostatic and insulinotropic action of glucagonlike peptide I-(7-36)-amide
doi: 10.1016/j.metabol.2012.03.002 21 HernandezA
